Eris Lifesciences Limited (NSE:ERIS)
India flag India · Delayed Price · Currency is INR
1,145.80
-38.90 (-3.28%)
Oct 7, 2026, 3:29 PM IST

Eris Lifesciences Company Description

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, GLP-1, and vitamins/minerals/nutrients.

It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram monitoring, continuous glucose monitoring system, sleep device, antenatal care, and early neuropathy screening solutions, as well as polycystic ovary syndrome screening, diagnosis, and management.

The company offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies.

Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.

Eris Lifesciences Limited
Eris Lifesciences logo
CountryIndia
Founded2007
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees2,758
CEOAmit Bakshi

Contact Details

Address:
Shivarth Ambit
Ahmedabad, 380054
India
Phone91 79 6966 1000
Websiteeris.co.in

Stock Details

Ticker SymbolERIS
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE406M01024
SIC Code2834

Key Executives

NamePosition
Amit Indubhushan BakshiChairman and MD
Sachin ShahChief Financial Officer
Krishnakumar VaidyanathanExecutive Director and Chief Operating Officer
Inderjeet Singh NegiExecutive Director
Kaushal Kamleshkumar ShahWhole Time Director
Vijay S. JoshiPresident of Medical
Murari RanganathanPresident of Cardiometabolic Business
Manish KapoorVice President
Ramprasad Krishnaraj BhatVice President
Nita Prasad BorkarVice President